Rarity is a mission‑driven public benefit biotech company developing accessible, affordable gene‑therapy treatments for rare diseases. Based in the United States, it focuses on creating life‑saving therapies that target the underlying genetic causes of these conditions, aiming to deliver lasting clinical outcomes for patients worldwide.
No recent news for this company.